Appraisal of Promising Repurposed Drug Candidates for the Treatment of SARS-CoV-2 Infection and COVID-19

Abstract

Since November 2019 the severe acute respiratory syndrome (SARS) or coronavirus disease 2019 (Covid 19) caused by the new human corona virus (HCoV), is spreading around the world, causing a major loss of lives.